Get the Stockscreener App
4.85
1.52%
0.0724
After Hours:
4.85
Pulmatrix Inc stock is traded at $4.85, with a volume of 5,967.
It is up +1.52% in the last 24 hours and up +4.30% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$4.7776
Open:
$4.69
24h Volume:
5,967
Relative Volume:
0.51
Market Cap:
$17.71M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-2.0124
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
-1.62%
1M Performance:
+4.30%
6M Performance:
-22.89%
1Y Performance:
+133.17%
1-Day Range:
$4.5868
$4.913
1-Week Range:
$4.5868
$4.9879
52-Week Range:
$2.00
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.85 | 17.45M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Is Pulmatrix Inc. stock a smart buy before Fed meetingPortfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
How Pulmatrix Inc. (2PU) stock responds to bond marketLayoff News & Safe Entry Point Alerts - newser.com
What drives Pulmatrix Inc stock priceInsider Trading Compliance & Exceptional Growth Investment - earlytimes.in
Analyzing Pulmatrix Inc. with risk reward ratio chartsJuly 2025 Trends & Community Consensus Picks - newser.com
What recovery options are there for Pulmatrix Inc.Sell Signal & AI Enhanced Trade Execution Alerts - newser.com
Trend analysis for Pulmatrix Inc. this week2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
Why institutional investors increase stakes in Pulmatrix Inc. (2PU) stock2025 Retail Activity & Daily Momentum Trading Reports - newser.com
Will breakout in Pulmatrix Inc. lead to full recoveryQuarterly Investment Review & Daily Stock Trend Reports - newser.com
Will Pulmatrix Inc. stock deliver consistent dividendsJuly 2025 Pullbacks & Verified Chart Pattern Signals - newser.com
Using RSI to spot recovery in Pulmatrix Inc.Market Trend Review & Low Risk Profit Maximizing Plans - newser.com
Why Pulmatrix Inc. (2PU) stock is a strong buy call2025 Sector Review & Weekly High Conviction Ideas - newser.com
Why Pulmatrix Inc. stock attracts high net worth investorsWeekly Volume Report & Target Return Focused Picks - newser.com
Is Pulmatrix Inc. stock gaining market shareEntry Point & High Accuracy Trade Signal Alerts - newser.com
What market sentiment indicators show for Pulmatrix Inc. (2PU) stockJuly 2025 News Drivers & Daily Technical Forecast Reports - newser.com
Real time pattern detection on Pulmatrix Inc. stock2025 Market Sentiment & Stepwise Entry and Exit Trade Signals - newser.com
Is Pulmatrix Inc. (2PU) stock prepared for digital transition2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Will Pulmatrix Inc. stock benefit from sector rotationJuly 2025 Pullbacks & Free Daily Entry Point Trade Alerts - fcp.pa.gov.br
Will Pulmatrix Inc. stock recover after recent drop2025 Short Interest & Community Verified Trade Signals - newser.com
What analysts say about Pulmatrix Inc 2PU stockTechnical Analysis Insights & Small Capital Investment Tips - earlytimes.in
Is Pulmatrix Inc. stock a good choice for value investors2025 Trading Recap & AI Enhanced Trading Signals - newser.com
Evaluating Pulmatrix Inc. with trendline analysisPrice Action & Safe Investment Capital Preservation Plans - newser.com
Is it time to cut losses on Pulmatrix Inc.Trade Volume Report & Community Consensus Stock Picks - newser.com
Is it too late to sell Pulmatrix Inc.Trade Entry Report & Weekly Setup with ROI Potential - newser.com
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):